These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6582779)

  • 1. A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia.
    Bussel JB; Steinherz PG; Miller DR; Hilgartner MW
    Am J Hematol; 1984 Jan; 16(1):83-90. PubMed ID: 6582779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma.
    Tefferi A; Owen BA; Nichols WL; Witzig TE; Owen WG
    Blood; 1989 Jul; 74(1):252-4. PubMed ID: 2752113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumor.
    Ts'ao C; Galluzzo TS; Hart SJ; Ng AS; Sorenson PG; Subbarao V
    Thromb Haemost; 1985 Dec; 54(4):768-72. PubMed ID: 3003955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound heparin/heparan sulfates in human adult and umbilical cord plasma.
    Xiao H; Miller SJ; Bang NU; Faulk WP
    Haemostasis; 1999; 29(4):237-46. PubMed ID: 10702706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma.
    Wages DS; Staprans I; Hambleton J; Bass NM; Corash L
    Am J Hematol; 1998 Aug; 58(4):285-92. PubMed ID: 9692391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.
    Liebman HA; Comenzo R; Allen ST; Dilorio JM
    Am J Hematol; 1991 Sep; 38(1):24-9. PubMed ID: 1897511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.
    Khoory MS; Nesheim ME; Bowie EJ; Mann KG
    J Clin Invest; 1980 Mar; 65(3):666-74. PubMed ID: 6444419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane.
    Han DK; Lee NY; Park KD; Kim YH; Cho HI; Min BG
    Biomaterials; 1995 Apr; 16(6):467-71. PubMed ID: 7654873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 20. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.